E

East Bay Rheumatology Medical Group, Inc. | San Leandro, CA

Research site

(Unclaimed)

Location

13851 East 14th Street, Suite 301, San Leandro, California, United States of America

Site insights

Top conditions

Top treatments

Methotrexate

Olokizumab

Ixekizumab

Baricitinib

Celecoxib

Ustekinumab

Prednisone

Atacicept

MTX

BMS-986165

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 27 total trials

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

The purpose of this study is to determine the safety and tolerability of imvotamab in patients with moderate to severe rheumatoid arthritis who have...

Enrolling

Arthritis

Arthritis, Rheumatoid

Drug: Placebo

Drug: Imvotamab

Locations recently updated

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Active, not recruiting

Rheumatoid Arthritis

Drug: Baricitinib

Drug: TNF Inhibitor

A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Enrolling

Rheumatoid Arthritis

Drug: Baricitinib

Drug: TNF Inhibitor

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (POETYK SLE-2)

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling

Systemic Lupus Erythematosus

Drug: Deucravacitinib

Other: Placebo